Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00888290 · ClinicalTrials.gov registry record · Phase 2
Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects
A Phase 2 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00888290 is a Phase 2 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 20 participants.
The verdict
NCT00888290, a Phase 2 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will enroll 25 patients with kidney disease to evaluate the effects of different doses of sodium bicarbonate (baking soda) on levels of bicarbonate in the blood, kidney function and muscle strength. The investigators will also evaluate safety and tolerability of different doses.
Interventions
- DRUG Sodium bicarbonate
- DRUG Placebos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00888290
The ClinicalTrials.gov registry entry for NCT00888290 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium bicarbonate is the first listed.
NCT00888290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00888290 about?
NCT00888290 is a clinical study titled "Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects". This study will enroll 25 patients with kidney disease to evaluate the effects of different doses of sodium bicarbonate (baking soda) on levels of bicarbonate in the blood, kidney function and muscle strength. The investigators will also evaluate safety and tolerability of different doses.
What is the current status of trial NCT00888290?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2009-03. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00888290?
The interventions under investigation include: Sodium bicarbonate (DRUG), Placebos (DRUG).
Who is sponsoring clinical trial NCT00888290?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.